Structured evidence table for Inositol Cardiometabolic Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Inositol Cardiometabolic Randomized Trial | Background Inositol and its derivatives may help mitigate risks associated with cardiovascular diseases; however, existing evidence remains inconsistent. | 1 | Delavar MA (2025) | Inositol supplementation efficacy in improving key cardiometabolic and anthropometric indices: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials. |
| Inositol Cardiometabolic Randomized Trial | Heterogeneity was assessed via the Cochrane Chi-squared test and Galbraith plots, while the ROBI tool evaluated bias risk. | 1 | Delavar MA (2025) | Inositol supplementation efficacy in improving key cardiometabolic and anthropometric indices: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials. |
| Inositol Cardiometabolic Randomized Trial | Significant reductions in BMI (WMD (95%CIs):-0.57 kg/m²(-1.10, -0.03), I²=88.6), waist-to-hip ratio(WMD (95%CI):-0.02(-0.04, -0.001), I²=84.1), and waist circumference (WMD (95%CI):-2.36 cm(-4.39, -0.33) I²=55.0) were noted with high heterogeneity and low to very low certainty evidence. | 1 | Delavar MA (2025) | Inositol supplementation efficacy in improving key cardiometabolic and anthropometric indices: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials. |
| Inositol Cardiometabolic Randomized Trial | Objectives The primary aim of this systematic review and meta-analysis of RCTs was to quantify the effects of inositol and its stereoisomers on anthropometric, and cardiometabolic measures. | 1 | Delavar MA (2025) | Inositol supplementation efficacy in improving key cardiometabolic and anthropometric indices: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials. |
Source documents